MCGOVERN; Dermot

Patent Applications and Registrations

Patent applications and USPTO patent grants for MCGOVERN; Dermot.The latest application filed is for "predicting extraintestinal manifestations of inflammatory bowel disease".

Company Profile

3.3.9

MCGOVERN; Dermot - Los Angeles CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Predicting Extraintestinal Manifestations Of Inflammatory Bowel Disease App 20220290241 - MCGOVERN; Dermot ; et al.	2022-09-15
Methods Of Treating Inflammatory Bowel Diseases That Target Ripk2 App 20220273665 - MCGOVERN; Dermot ; et al.	2022-09-01
Methods Of Treating And Diagnosing Inflammatory Bowel Disease App 20220260565 - Underhill; David ; et al.	2022-08-18
Therapeutically Triggering an Innate Immune Response in a Target Tissue App 20220236284 - Gunn; Harold David ; et al.	2022-07-28
Methods Of Predicting Non-response To Anti-tnf Treatment In Subjects With Inflammatory Bowel Disease App 20220153855 - McGOVERN; Dermot ; et al.	2022-05-19
Therapeutically triggering an innate immune response in a target tissue Grant 11,226,340 - Gunn , et al. January 18, 2	2022-01-18
Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease Grant 11,180,565 - McGovern , et al. November 23, 2	2021-11-23
Dysregulation Of Covid-19 Receptor Associated With Ibd App 20210332122 - MCGOVERN; Dermot ; et al.	2021-10-28
Methods Of Predicting Non-response To Anti-tnf Treatment In Subjects With Inflammatory Bowel Disease App 20200231690 - McGovern; Dermot ; et al.	2020-07-23
Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease Grant 10,626,180 - McGovern , et al.	2020-04-21
Therapeutically Triggering an Innate Immune Response in a Target Tissue App 20190134172 - Gunn; Harold David ; et al.	2019-05-09
Methods Of Predicting Non-response To Anti-tnf Treatment In Subjects With Inflammatory Bowel Disease App 20180305459 - McGovern; Dermot ; et al.	2018-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.